Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Public ClinicalTrials.gov record NCT01311557. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of study Td519 is to demonstrate that Adacel® vaccine (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed) is safe and immunogenic in persons 10 years of age. Primary Objectives: * To compare pertussis antibody responses induced by Adacel® in persons 10 to \<11 years of age to those induced by Adacel in persons 11 to \<12 years of age. * To compare the booster responses against pertussis antigens induced by Adacel in persons 10 to \<11 years of age to those induced by Adacel in persons 11 to \<12 years of age. * To compare booster responses against tetanus and diphtheria induced by Adacel in persons 10 to \<11 years of age to those induced by Adacel in persons 11 to \<12 years of age. Secondary Objective: * To compare seroprotection rates against tetanus and diphtheria induced by Adacel in persons 10 to \<11 years of age to those induced by Adacel in persons 11 to \<12 years of age.
Study identification
- NCT ID
- NCT01311557
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,302 participants
Conditions and interventions
Conditions
Interventions
Biological
Eligibility (public fields only)
- Age range
- 10 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2011 (Type not available)
- Primary completion
- Nov 2011 (Actual)
- Completion
- Jan 2012 (Actual)
- Last update posted
- Apr 8, 2016
2011 – 2012
United States locations
- U.S. sites
- 34
- U.S. states
- 23
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Chandler | Arizona | 85224 | — |
| Not listed | Jonesboro | Arkansas | 72401 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Sacramento | California | 95816 | — |
| Not listed | Longmont | Colorado | 80501 | — |
| Not listed | Norwich | Connecticut | 06360 | — |
| Not listed | Miami Beach | Florida | 33141 | — |
| Not listed | Marietta | Georgia | 30062 | — |
| Not listed | Woodstock | Georgia | 30189 | — |
| Not listed | Bardstown | Kentucky | 40040 | — |
| Not listed | Crestview Hills | Kentucky | 41017 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Madisonville | Kentucky | 42431 | — |
| Not listed | Haughton | Louisiana | 71037 | — |
| Not listed | Metairie | Louisiana | 70006 | — |
| Not listed | Woburn | Massachusetts | 01801 | — |
| Not listed | Plymouth | Minnesota | 55441 | — |
| Not listed | Rochester | New York | 14609 | — |
| Not listed | Cleveland | Ohio | 44121 | — |
| Not listed | Pittsburgh | Pennsylvania | 15241 | — |
| Not listed | Warwick | Rhode Island | 02886 | — |
| Not listed | Barnwell | South Carolina | 29812 | — |
| Not listed | Rapid City | South Dakota | 57701 | — |
| Not listed | Kingsport | Tennessee | 37660 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Fort Worth | Texas | 76135 | — |
| Not listed | San Antonio | Texas | 78205 | — |
| Not listed | Orem | Utah | 84057 | — |
| Not listed | Salt Lake City | Utah | 84124 | — |
| Not listed | South Jordan | Utah | 84095 | — |
| Not listed | Midlothian | Virginia | 23113 | — |
| Not listed | Vienna | Virginia | 22180 | — |
| Not listed | Spokane | Washington | 99202 | — |
| Not listed | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01311557, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2016 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01311557 live on ClinicalTrials.gov.